Grant: Engage Grants Program
McMaster University
$25,000.00
Placenta-chip for new biomarker discovery and production technologies
EF 2014-15
Résumé
This project develops a microfluidic device that is used to cultivate Placental cells for production of proteins such as hyperglycosylated-hCG that are used as important biomarkers in diagnostic assays. Our partner, Evik Diagnostics, is interested in developing a reliable supply of human biomarkers for use in their diagnostics assays in the area of maternal health and cancer screening. These biomarkers are produced naturally in the placenta. Therefore, mimicking the in-vivo organisation of cells in the placenta can create the right culture conditions that will promote the growth of placental stem cells and production of the biomarker proteins. In this project, we will use our expertise in microfluidics and microbioreactor design to fabricate microfluidic scaffolds that allow seeding of various cell types that constitute the human placenta and determine conditions that will promote the growth of placental stem cells. We will also investigate the production of the biomarker proteins, especially hyperglycosylated-hCG, in these bioreactors and identify if this technology would be suitable for reliable supply for diagnostic applications. The outcomes of this project will be a significant benefit to our partner, Evik Diagnostics, in ensuring quality control of their products and maintaining a in-house reliable production of the proteins. This project will also develop interdisciplinary skills in the students and the interaction with industrial partner will be an excellent training for the students.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
477532-2014
Name nom
Selvaganapathy, Ponnambalam
Department département
Mechanical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Placenta-chip for new biomarker discovery and production technologies
Keyword
NSERC
Application summary
This project develops a microfluidic device that is used to cultivate Placental cells for production of proteins such as hyperglycosylated-hCG that are used as important biomarkers in diagnostic assays. Our partner, Evik Diagnostics, is interested in developing a reliable supply of human biomarkers for use in their diagnostics assays in the area of maternal health and cancer screening. These biomarkers are produced naturally in the placenta. Therefore, mimicking the in-vivo organisation of cells in the placenta can create the right culture conditions that will promote the growth of placental stem cells and production of the biomarker proteins. In this project, we will use our expertise in microfluidics and microbioreactor design to fabricate microfluidic scaffolds that allow seeding of various cell types that constitute the human placenta and determine conditions that will promote the growth of placental stem cells. We will also investigate the production of the biomarker proteins, especially hyperglycosylated-hCG, in these bioreactors and identify if this technology would be suitable for reliable supply for diagnostic applications. The outcomes of this project will be a significant benefit to our partner, Evik Diagnostics, in ensuring quality control of their products and maintaining a in-house reliable production of the proteins. This project will also develop interdisciplinary skills in the students and the interaction with industrial partner will be an excellent training for the students.